Skip to main content
Signal8

WITTE OWEN N.

SEC insider (Form 3/4/5 filer). CIK 0001700969. Director at Allogene Therapeutics, Inc. (ALLO). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies WITTE OWEN N. has filed insider reports for

  • Allogene Therapeutics, Inc. (ALLO): Director
WITTE OWEN N. profile photo

WITTE OWEN N.

CIK: 0001700969

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Allogene Therapeutics, Inc. logo
ALLO

Allogene Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Allogene Therapeutics, Inc. logo
    ALLO

    Allogene Therapeutics, Inc.

    Jun 18, 2026
    Award

    Restricted Stock Unit

    Direct
    95.4K shares-
  • Allogene Therapeutics, Inc. logo
    ALLO

    Allogene Therapeutics, Inc.

    Jun 18, 2025
    Award

    Restricted Stock Unit

    Direct
    95.4K shares-

1-2 of 2